Autopsy report · NCT03952598
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy
Cause of deathOther
“Study on hold pending possible updates with the team.”
Life of this trial
- Registered 5 months before it started.
- Suspended: paused, and may or may not restart.
- 42 participants enrolled.
Vital statistics
- Status
- Suspended
- Phase
- Phase 2
- Sponsor
- National Cancer Institute (NCI)
- Sponsor type
- US National Institutes of Health
- Conditions
- Glioma; Gliomas; High Grade Glioma; Malignant Glioma; Low Grade Glioma
- Interventions
- HP 13C Pyruvate; 3T MRI scanner
- Participants
- 42
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.